Prevention of In-hospital Adverse Events
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Prevention of In-hospital Adverse Events trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Prevention of In-hospital Adverse Events trials you may qualify forOBJECTIVE : To compare the outcome of treatment with silymarin or N-acetyl cysteine in patients taking anti-tuberculous drugs for tuberculosis at Tertiary Care…
Adjuvant chemotherapy with the protocol 3 cure of 5-FU + Epirubicine + Cyclophosphamide (FEC100) and 3 cure of Taxotere is a standard treatment in the managemen…